Hundreds of thousands of medical marijuana products might be at risk after the Pennsylvania Department of Health ordered a secondary review of vaporized cannabis products last week, according to reports.
MJBizDaily.com reports that Mark O’Neil, the press secretary for the Department of Health, confirmed that the state’s Medical Marijuana office ordered a statewide review of “vaporized medical marijuana products” on Nov. 16 in an effort to ensure the permitted growers and processors of these products “are not using additives that are not safe for inhalation.”
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
By Hilary Bricken, Attorney at Husch Blackwell Dealing with creditors is never a fun experience. However, some creditors are more severe than others, especially in the cannabis industry. One of…
The long wait on whether Floridians will get a chance to vote to legalize recreational cannabis for adults 21 and older is almost over, as the Florida Supreme Court is…
Missouri’s health department on Wednesday stripped two coveted marijuana micro-licenses tied to an out-of-state company that had been accused of predatory practices and had listed the licenses for resale. The…
Big Island Grown (BIG) is a vertically integrated cannabis company based in Kailua-Kona, Hawaii County, on the Big Island of Hawaii, whose reach now extends to several islands in the…